Rainbow Biosciences Articles
Rainbow Biosciences in talks to license NASA bioreactor technology
20 September 2012
Rainbow Coral seeks place in $84.6 billion biotechnology sector, forming new division; AMAG merger with Allos called off
23 October 2011
Showing 1-4 of 4 articles
- 1
- FDA probes two deaths possibly linked to Lilly's antipsychotic Zyprexa Relprevv
- Negative US patent ruling for Novo Nordisk on Prandin
- Aspen Pharma offers to buy GlaxoSmithKline's thrombosis brands and manufacturing site
- US Supreme Court says patent settlement can "sometimes" be illegal
- Daiichi Sankyo files for Japanese approval of Prasugrel
